Atlas Trials

Fluvoxamine for Long COVID-19

Clinical trial NCT05874037 · COMPLETED

Trial details

NCT number
NCT05874037
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Long COVID
Start date
2023-05-15
Primary completion
2025-03-15
Enrollment
191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.